Analysen von Nicolas Guyon-Gellin
| 09.02.17 | GSK Equal-Weight | Morgan Stanley | |
| 06.02.17 | GSK Equal-Weight | Morgan Stanley | |
| 04.11.16 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 31.10.16 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 11.07.16 | GSK Equal-Weight | Morgan Stanley | |
| 31.05.16 | GSK Equal-Weight | Morgan Stanley | |
| 28.04.16 | GSK Equal-Weight | Morgan Stanley | |
| 20.04.16 | GSK Equal-Weight | Morgan Stanley | |
|
Werbung
|
|||
| 04.02.16 | GSK Equal-Weight | Morgan Stanley | |
| 06.11.15 | GSK Equal-Weight | Morgan Stanley | |
| 05.11.15 | GSK Equal-Weight | Morgan Stanley | |
| 21.10.15 | GSK Equal-Weight | Morgan Stanley | |
| 30.07.15 | GSK Equal-Weight | Morgan Stanley | |
| 04.06.15 | GSK Equal-Weight | Morgan Stanley | |
| 29.09.14 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 19.11.12 | Merck neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Merck neutral | Exane-BNP Paribas SA | |
| 25.10.12 | Ipsen neutral | Exane-BNP Paribas SA | |
| 23.10.12 | Elan neutral | Exane-BNP Paribas SA | |